Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANGALAM DRUGS vs BROOKS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MANGALAM DRUGS BROOKS LAB MANGALAM DRUGS/
BROOKS LAB
 
P/E (TTM) x 18.0 232.4 7.7% View Chart
P/BV x 1.2 5.8 21.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 MANGALAM DRUGS   BROOKS LAB
EQUITY SHARE DATA
    MANGALAM DRUGS
Mar-24
BROOKS LAB
Mar-24
MANGALAM DRUGS/
BROOKS LAB
5-Yr Chart
Click to enlarge
High Rs132185 71.5%   
Low Rs9157 158.7%   
Sales per share (Unadj.) Rs232.830.3 769.0%  
Earnings per share (Unadj.) Rs-5.7-7.5 76.8%  
Cash flow per share (Unadj.) Rs3.5-6.8 -51.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs85.825.0 343.3%  
Shares outstanding (eoy) m15.8326.25 60.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.54.0 12.0%   
Avg P/E ratio x-19.4-16.2 119.9%  
P/CF ratio (eoy) x31.6-17.8 -177.3%  
Price / Book Value ratio x1.34.8 26.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,7643,178 55.5%   
No. of employees `000NANA-   
Total wages/salary Rs m391101 387.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,686795 463.7%  
Other income Rs m111 8.8%   
Total revenues Rs m3,687806 457.4%   
Gross profit Rs m174-181 -96.3%  
Depreciation Rs m14718 826.3%   
Interest Rs m1398 1,647.0%   
Profit before tax Rs m-111-196 56.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-200 -7,700.0%   
Profit after tax Rs m-91-196 46.3%  
Gross profit margin %4.7-22.7 -20.8%  
Effective tax rate %18.1-0.1 -13,655.0%   
Net profit margin %-2.5-24.6 10.0%  
BALANCE SHEET DATA
Current assets Rs m1,760310 566.9%   
Current liabilities Rs m1,641230 711.8%   
Net working cap to sales %3.210.1 32.2%  
Current ratio x1.11.3 79.6%  
Inventory Days Days2210 1.1%  
Debtors Days Days277749 36.9%  
Net fixed assets Rs m1,577594 265.5%   
Share capital Rs m158262 60.3%   
"Free" reserves Rs m1,200393 305.0%   
Net worth Rs m1,358656 207.0%   
Long term debt Rs m1340-   
Total assets Rs m3,337904 369.0%  
Interest coverage x0.2-22.2 -0.9%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.10.9 125.7%   
Return on assets %1.5-20.7 -7.0%  
Return on equity %-6.7-29.9 22.4%  
Return on capital %1.9-28.5 -6.7%  
Exports to sales %00-   
Imports to sales %23.60-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m870NA-   
Fx inflow Rs m1,6890-   
Fx outflow Rs m8790-   
Net fx Rs m8100-   
CASH FLOW
From Operations Rs m39-97 -40.4%  
From Investments Rs m-1182 -6,498.4%  
From Financial Activity Rs m5296 54.4%  
Net Cashflow Rs m-271 -2,635.3%  

Share Holding

Indian Promoters % 50.3 63.6 79.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 3.9 2.8%  
FIIs % 0.1 0.0 550.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.7 36.4 136.5%  
Shareholders   19,508 11,282 172.9%  
Pledged promoter(s) holding % 10.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MANGALAM DRUGS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on MANGALAM DRUGS vs BROOKS LAB

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MANGALAM DRUGS vs BROOKS LAB Share Price Performance

Period MANGALAM DRUGS BROOKS LAB S&P BSE HEALTHCARE
1-Day 0.00% 1.99% 0.92%
1-Month 1.47% 6.95% 1.24%
1-Year 9.81% 12.34% 46.23%
3-Year CAGR -5.17% 9.33% 19.63%
5-Year CAGR 29.24% 41.22% 26.12%

* Compound Annual Growth Rate

Here are more details on the MANGALAM DRUGS share price and the BROOKS LAB share price.

Moving on to shareholding structures...

The promoters of MANGALAM DRUGS hold a 50.3% stake in the company. In case of BROOKS LAB the stake stands at 63.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MANGALAM DRUGS and the shareholding pattern of BROOKS LAB.

Finally, a word on dividends...

In the most recent financial year, MANGALAM DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

BROOKS LAB paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of MANGALAM DRUGS, and the dividend history of BROOKS LAB.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.